Artwork

Content provided by Vinay Prasad, MD MPH, Vinay Prasad, and MD MPH. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Vinay Prasad, MD MPH, Vinay Prasad, and MD MPH or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

3.86 Lenvatinib plus Pembrolizumab or Everolimus for Advanced RCC with Dr. Karine Tawagi

34:41
 
Share
 

Manage episode 293609920 series 2547109
Content provided by Vinay Prasad, MD MPH, Vinay Prasad, and MD MPH. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Vinay Prasad, MD MPH, Vinay Prasad, and MD MPH or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Today we bring back our popular Journal Club with a Fellow segment. We're joined by Dr. Karine Tawagi of the Oschner Clinic in Louisiana to discuss the CLEAR trial: "Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma" as published in the New England Journal of Medicine. CLEAR: doi.org/10.1056/NEJMoa2035716 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew
  continue reading

375 episodes

Artwork
iconShare
 
Manage episode 293609920 series 2547109
Content provided by Vinay Prasad, MD MPH, Vinay Prasad, and MD MPH. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Vinay Prasad, MD MPH, Vinay Prasad, and MD MPH or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Today we bring back our popular Journal Club with a Fellow segment. We're joined by Dr. Karine Tawagi of the Oschner Clinic in Louisiana to discuss the CLEAR trial: "Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma" as published in the New England Journal of Medicine. CLEAR: doi.org/10.1056/NEJMoa2035716 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew
  continue reading

375 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide